| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/02/2002 | DE10053512A1 10C terpene alcohols ethoxyated with 3-10 mols of ethylene oxide are used as solubilizers for difficultly water-soluble or -dispersible compounds in pharmaceutical or cosmetic compositions or in food concentrates |
| 05/02/2002 | DE10053397A1 Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen Use of a dopaminergic agent for the treatment of dopaminergic treatable diseases |
| 05/02/2002 | DE10052322A1 Storage-stable solid chlorhexidine composition used for preparing aqueous disinfectant solutions e.g. for skin disinfection contains sugar acid and microbicidal quaternary ammonium bromide |
| 05/02/2002 | CA2427068A1 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | CA2426360A1 Enhancers for microbiological disinfection and targeted apoptosis |
| 05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
| 05/02/2002 | CA2426128A1 Rheology modifying copolymer composition |
| 05/02/2002 | CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/02/2002 | CA2422900A1 New composition and method for the treatment of dysglucaemia |
| 05/02/2002 | CA2422786A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 05/02/2002 | CA2420590A1 Active agent delivery systems and methods for protecting and administering active agents |
| 05/02/2002 | CA2325765A1 Method for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 05/01/2002 | CN1347450A Composition for preservation of infections recombinant adenoviruses |
| 05/01/2002 | CN1347328A Dry acid-chitosan complexes |
| 05/01/2002 | CN1347327A Methods for glucagon suppression |
| 05/01/2002 | CN1347315A Method for producing water-insoluble amorphous or partially amorphous controlled release matrix |
| 05/01/2002 | CN1347313A High potency dihydroergotamine compositions |
| 05/01/2002 | CN1347307A Cosmetic preparations |
| 05/01/2002 | CN1346824A Carotenoid ester |
| 05/01/2002 | CN1083716C Menstruum for penicillin anaphylaxis intracutaneous test |
| 05/01/2002 | CN1083713C Bilayer preparations |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380248 Metal-thiols as immunomodulating agents |
| 04/30/2002 | US6380236 Method of treating onychomycosis |
| 04/30/2002 | US6380234 Homogenity mixing, granulation, enteric coating |
| 04/30/2002 | US6380198 Lowering the intraocular pressure |
| 04/30/2002 | US6380181 Synthetic catechol derivatives, method for production and use thereof |
| 04/30/2002 | US6380172 Monomeric lipophilic oligosaccharide antibiotic compositions |
| 04/30/2002 | US6380163 Containing osmotic agent with an additional osmotic agent such as dextrose |
| 04/30/2002 | US6380161 Therapy of cancer, wherein a cancer chemotherapy agent is selected, conjugated to peptide, and one dose is administered to patient in therapeutically effective amount, and wherein peptide binds to a receptor for thrombospondin |
| 04/30/2002 | US6379965 Nucleic acid noncovalently associated with a polyamine compound that is covalently attached to an endosome disrupting agent such as cholic acid; nonviral vectors |
| 04/30/2002 | US6379962 Polymer scaffold having microporous polymer struts defining interconnected macropores |
| 04/30/2002 | US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life |
| 04/30/2002 | US6379706 Rapidly disintegrating coated pellets with delayed release |
| 04/30/2002 | US6379704 Method for preparing microparticles having a selected polymer molecular weight |
| 04/30/2002 | US6379702 Flexibility; contour conforming; applying to skins |
| 04/30/2002 | US6379701 Controlled release of metal cation-stabilized interferon |
| 04/30/2002 | US6379700 An oil-in-water fluid emulsion prepared by phase inversion and comprising an emulsifier is sprayed at room temperature onto a powder, e.g. drugs, to coat; compression to obtain tablets |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379698 Fusogenic lipids and vesicles |
| 04/30/2002 | US6379696 Adjust absorption |
| 04/30/2002 | US6379695 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis |
| 04/30/2002 | US6379688 Preservative for emulsion and emulsion containing same |
| 04/30/2002 | US6379683 Lipid core encapsulated with polymer |
| 04/30/2002 | US6379682 Cosmetics, drugs |
| 04/30/2002 | US6379669 Drug delivery to prostate gland |
| 04/30/2002 | US6379660 Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and composition comprising same |
| 04/30/2002 | US6378527 Cell-culture and polymer constructs |
| 04/30/2002 | CA2203663C Cisapride extended release oral compositions |
| 04/30/2002 | CA2194976C Wound healing agent |
| 04/30/2002 | CA2177823C Poly-beta-1-->4-n-acetylglucosamine |
| 04/30/2002 | CA2096963C A two-phase topical composition |
| 04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/27/2002 | CA2360034A1 Multicore type carotenoid beads |
| 04/27/2002 | CA2359401A1 Use of terpene alcohol ethoxylates as solubilizers in cosmetic or pharmaceutical preparations or concentrates for food preparations |
| 04/25/2002 | WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | WO2002033044A2 Methods of high-throughput screening for internalizing antibodies |
| 04/25/2002 | WO2002032963A1 Immunoadjuvant systems |
| 04/25/2002 | WO2002032957A1 Peg-modified erythropoietin |
| 04/25/2002 | WO2002032941A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/25/2002 | WO2002032914A2 Acylated cellobiose compounds |
| 04/25/2002 | WO2002032462A1 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 04/25/2002 | WO2002032461A2 Protein c or activated protein c-like molecules |
| 04/25/2002 | WO2002032459A2 Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
| 04/25/2002 | WO2002032436A1 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 04/25/2002 | WO2002032435A2 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade |
| 04/25/2002 | WO2002032431A1 Compositions for external preparations |
| 04/25/2002 | WO2002032428A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
| 04/25/2002 | WO2002032424A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
| 04/25/2002 | WO2002032423A1 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/25/2002 | WO2002032410A2 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 04/25/2002 | WO2002032406A2 Methods and products related to pulmonary delivery of polysaccharides |
| 04/25/2002 | WO2002032404A2 Nanoparticles |
| 04/25/2002 | WO2002032402A1 Composition and method for stable injectable liquids |
| 04/25/2002 | WO2002032400A1 Liposomal formulation of mitoxantrone |
| 04/25/2002 | WO2002032399A1 Taxol liposome composition for treatment of cancer and preparation thereof |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032376A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 04/25/2002 | WO2002032375A2 Uses of monoclonal antibody 8h9 |
| 04/25/2002 | WO2002032234A1 Anti-stress composition designed to be mainly incorporated in nutritional carriers |
| 04/25/2002 | WO2002032233A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 04/25/2002 | WO2001093833A3 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 04/25/2002 | WO2001093831A3 Low carbohydrate compositions, kits thereof, and methods of use |
| 04/25/2002 | WO2001080897A3 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 04/25/2002 | WO2001062300A3 Caspase activated prodrugs therapy |
| 04/25/2002 | WO2001060848A3 Conjugates targeted to target receptors |
| 04/25/2002 | WO2001058940A3 Adenoviral capsid containing chimeric protein IX |
| 04/25/2002 | WO2001041810A3 Nucleic acid delivery system |
| 04/25/2002 | WO2001028521A3 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/25/2002 | US20020049997 Methods for producing and transforming cassava protoplasts |
| 04/25/2002 | US20020049252 Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid |
| 04/25/2002 | US20020049247 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes... |
| 04/25/2002 | US20020049233 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049158 Increasing bioavailability of a drug which is not readily absorbed in the digestive tract |
| 04/25/2002 | US20020049156 Polyhudroxy glycopeptide derivatives |
| 04/25/2002 | US20020049155 Cobalamin compounds useful as cardiovascular agents and as imaging agents |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |